drugset / Trial / NCT05959499

A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fed Conditions in Healthy Adult Volunteers

NCT05959499 ↗

Phase 1 Completed 40 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelPrevention

Summary

The purpose of this clinical trial is evaluate the pharmacokinetics and safety between single administration of "BR6002" and coadministration of "BR6002A" and "BR6002B" under fed conditions in healthy adult volunteers

Timeline

Start
2023-07-13
Primary completion
2023-09-12
Completion
2023-09-12

Drugs

EvaluationDrugModalityDoseRoute
Subject BR6002 Unknown — —
Comparator BR6002A Unknown — —
Comparator BR6002B Unknown — —

Indications